Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Juan Qiu

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Observation of clinical response of "sheng ban recipe" for platelets decrease after chemotherapy]Bei Zhang, Pi-Li Hu, Hui-Juan Qiu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 25, 2010
[Short-term outcomes of 16 patients with non-small cell lung cancer receiving cetuximab combined with standard chemotherapy in the first and non-first line settings]Hui-juan Qiu, Liang-ping Xia, Fang Wang, et al.
Chinese Journal of Cancer|January 30, 2010
Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institutionFei-Fei Zhou, Liang-Ping Xia, Xi Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 16, 2003
[Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma]Guo-Xian Huang, Chong Zhao, Fei Han, et al.
Oncotargets and Therapy|June 26, 2015
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinomaLi Jiang, Liang Wang, Peng-Fei Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 18, 2010
[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status]Gui-fang Guo, Liang-ping Xia, Hui-juan Qiu, et al.
Journal of Cancer|March 7, 2017
Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer PatientsWen-Zhuo He, Fang-Xin Liao, Chang Jiang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Prognostic model built on blood-based biomarkers in patients with metastatic colorectal cancerWen-Zhuo He, Chang Jiang, Chen-Xi Yin, et al.
Chinese Journal of Cancer|July 1, 2016
Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigenWen-Zhuo He, Yu-Ming Rong, Chang Jiang, et al.
Plos One|February 21, 2012
The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in ChinaMiao-zhen Qiu, Hui-juan Qiu, Zhi-qiang Wang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Observation of clinical response of "sheng ban recipe" for platelets decrease after chemotherapy]Bei Zhang, Pi-Li Hu, Hui-Juan Qiu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 25, 2010
[Short-term outcomes of 16 patients with non-small cell lung cancer receiving cetuximab combined with standard chemotherapy in the first and non-first line settings]Hui-juan Qiu, Liang-ping Xia, Fang Wang, et al.
Chinese Journal of Cancer|January 30, 2010
Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institutionFei-Fei Zhou, Liang-Ping Xia, Xi Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 16, 2003
[Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma]Guo-Xian Huang, Chong Zhao, Fei Han, et al.
Oncotargets and Therapy|June 26, 2015
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinomaLi Jiang, Liang Wang, Peng-Fei Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 18, 2010
[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status]Gui-fang Guo, Liang-ping Xia, Hui-juan Qiu, et al.
Journal of Cancer|March 7, 2017
Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer PatientsWen-Zhuo He, Fang-Xin Liao, Chang Jiang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Prognostic model built on blood-based biomarkers in patients with metastatic colorectal cancerWen-Zhuo He, Chang Jiang, Chen-Xi Yin, et al.
Chinese Journal of Cancer|July 1, 2016
Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigenWen-Zhuo He, Yu-Ming Rong, Chang Jiang, et al.
Plos One|February 21, 2012
The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in ChinaMiao-zhen Qiu, Hui-juan Qiu, Zhi-qiang Wang, et al.
Pageof 4